Dr. Catherine Flores will expand her research into a new use of stem cells to enhance the clinical effectiveness of adoptive T cell therapy against brain tumors.
Dr. Matthew Farrer, recognized for his work on the genetics of Parkinson’s disease, will join UF Health on Sept. 1.
In the Conversation, Dr. Steven DeKosky weighs in on a new report discouraging the use of dietary supplements to prevent cognitive decline, dementia or Alzheimer's.
State-of-the-art building will feature some of the foremost experts in Parkinson’s and other neurological conditions.
Collaborators from the Fixel Institute and MBI will pilot a novel, low-cost intervention to improve Parkinson’s symptoms.
In the journal JAMA Neurology, Dr. Michael Okun discusses the challenge of selecting an appropriate DBS system for an individual patient.
Dr. James Wymer among national team of researchers to identify novel pathway for potential treatment of the disfiguring condition, neurofibromatosis 1.
National Institute of Neurological Disorders and Stroke leadership recently visited with Predoctoral Interdisciplinary Training in Movement Disorders and Neurorestoration program participants.
Dr. David R. Nelson has been named senior vice president for health affairs at the University of Florida and president of UF Health.
Dr. Michael Okun is an author of a new AAN guideline for the treatment of tics in Tourette syndrome and other chronic tic disorders.